For the year ending 2025-12-31, INKT has $14,238,842 in assets. $13,360,340 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 13,360,340 | |||
| Prepaid expenses | 276,431 | |||
| Other current assets | 211,202 | |||
| Total current assets | 13,847,973 | |||
| Equipment, net of accumulated depreciation of 612,245 and 524,639 at december 31, 2025 and december 31, 2024, respectively | 390,869 | |||
| Total assets | 14,238,842 | |||
| Accounts payable | 3,425,314 | |||
| Accrued liabilities | 1,579,147 | |||
| Related party note | 5,179,444 | |||
| Other current liabilities | 2,847,543 | |||
| Total current liabilities | 13,031,448 | |||
| Due to related parties | 15,435,053 | |||
| Common stock, par value 0.00001 per share, 150,000,000 shares authorized, 4,706,246 and 3,963,045 shares issued at december 31, 2025 and december 31, 2024, respectively | 48 | |||
| Additional paid-in capital | 143,167,204 | |||
| Accumulated other comprehensive loss | -718,916 | |||
| Accumulated deficit | -156,675,995 | |||
| Total stockholders' deficit | -14,227,659 | |||
| Total liabilities and stockholders' deficit | 14,238,842 | |||
MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics, Inc. (INKT)